US-CONGRESS HR1657: Humane Cosmetics Act of 2025
The Humane Cosmetics Act of 2025 has been referred to the House Committee on Energy and Commerce. If enacted, it would ban animal testing for cosmetics and prohibit the sale of cosmetics tested on animals, impacting all businesses in the cosmetics supply chain.
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 28, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. All cosmetics businesses including indie brands, contract manufacturers, private-label makers, and importers/distributors selling in the US. should confirm how it applies to their specific situation before acting. There is a time constraint attached: No immediate deadline; bill is in early stages. However, businesses should start planning now to comply if passed.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Introduction of a bill that would ban animal testing for cosmetics and prohibit sale of animal-tested cosmetics in the US.
Who it affects
All cosmetics businesses including indie brands, contract manufacturers, private-label makers, and importers/distributors selling in the US.
What you must do
Monitor bill progress; prepare to transition to non-animal testing methods and update supply chain documentation.
Deadline
No immediate deadline; bill is in early stages. However, businesses should start planning now to comply if passed.
Source: https://www.congress.gov/bill/119th-congress/house-bill/1657
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- Continuing the Suspension of Duty-Free De Minimis Treatment for All Countries
- California Prop 65: DEA Judgment Reinforces First Amendment Limits on Warning Requirements - The National Law Review
- Proposition 65: California Attorney General Stipulates to Judgment Prohibiting Warning Requirements for DEA - The National Law Review
- Proposal to Revoke the Color Additive Listing for Use of Citrus Red No. 2 on the Skins of Mature Oranges
- US-CONGRESS BILLS-119hr2821eh: FDA Modernization Act 3.0